Streetbeat News

Equity Actions

BDRX

Biodexa Pharmaceuticals has filed for an offering of up to 1.3 million ordinary shares by the selling shareholders, according to a filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:37 pm

ACXP

Acurx Pharmaceuticals' shares have declined following the company's announcement of a common stock offering. This move typically dilutes existing shareholders' value, leading to a negative reaction in the stock market.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:35 pm

ADVM

Adverum Biotechnologies announced a 1-for-10 reverse stock split, approved by its Board of Directors on March 8, to be effective on March 21, 2024. This adjustment will result in approximately 20.8 million shares of common stock outstanding.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:10 pm

BTDR

Bitdeer Technologies Group has filed for a mixed shelf offering of up to $750 million, according to a Reuters report citing a recent filing. This move could potentially allow the company to raise capital by issuing various types of securities over time.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:10 pm

ACXP

Acurx Pharmaceuticals Inc has filed for a common stock offering, although the size of the offering has not been disclosed. This move could potentially dilute current shareholders but also provide the company with necessary capital for its operations and development projects.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:08 pm

HTCR

HeartCore Enterprises, Inc. has signed its 13th Go IPO contract, expecting to receive $500,000 in initial fees and $300,000 in success fees. Additionally, the company has received a warrant to acquire 3% of PharmaBio's stock on a fully diluted basis.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:08 pm

BLKB

Blackbaud (NASDAQ:BLKB) announced the termination of its stockholder rights plan effective March 18, 2024, ahead of its original expiry date on October 2, 2024. The Board unanimously voted for the termination, deeming the Rights Plan unnecessary for serving stockholder interests at this time.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:07 pm

MDGL

Madrigal Pharmaceuticals has announced a proposed public offering of $500 million worth of common stock and pre-funded warrants. This move is aimed at raising capital, potentially for further research, development, and expansion of its operations.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:05 pm

DLO

dLocal has appointed Mark Ortiz as its new CFO, replacing Diego Cabrera Canay. Ortiz will oversee various financial and accounting functions, reporting directly to CEO Pedro Arnt. This move aims to strengthen dLocal's leadership team.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:04 pm

NCMI

National CineMedia announced a new $100M share repurchase program, signaling confidence in the company's financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:02 pm